Brevan Howard Capital Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
26,800
-58,847
-69% -$4.29M 0.02% 706
2026
Q1
$5.59M Buy
85,647
+63,151
+281% +$4.69M 0.05% 209
2025
Q4
$1.78M Buy
22,496
+19,049
+553% +$1.46M 0.02% 522
2025
Q3
$252K Buy
+3,447
New +$253K ﹤0.01% 1652
2025
Q2
– Sell
-4,735
Closed -$360K – 2043
2025
Q1
$360K Buy
+4,735
New +$353K ﹤0.01% 808
2024
Q4
– Sell
-11,869
Closed -$828K – 1506
2024
Q3
$828K Buy
+11,869
New +$714K 0.01% 513

Other funds holding SOLV

Brevan Howard Capital Management's SOLV Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Solventum (SOLV) stake by 69% in Q2 2026, selling an estimated $4.29M and leaving 26,800 shares worth $2.07M. The position accounts for 0.02% of the portfolio, ranked #706.

Brevan Howard Capital Management first reported a position in SOLV in Q3 2024 and has held it in 6 quarters since. The position peaked at $5.59M in Q1 2026. 885 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Brevan Howard Capital Management held 26,800 shares of Solventum worth $2.07M as of Q2 2026.
  • Brevan Howard Capital Management sold 58,847 Solventum shares in Q2 2026, an estimated $4.29M.
  • Solventum made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #706 holding.
  • Brevan Howard Capital Management first reported a position in Solventum in Q3 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Solventum position peaked at $5.59M in Q1 2026.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.